Broadfin Capital’s Natus Medical Inc NTUS Stock Holding History

Broadfin Capital’s Portfolio NTUS Stock Details NTUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-113,526	Closed	-$3.82M	–	61
2018 Q1	$3.82M	Sell	113,526 -90,874	-44%	-$2.88M	0.6%	38
2017 Q4	$7.81M	Hold	204,400	–	–	1.28%	22
2017 Q3	$7.67M	Buy	204,400 +92,900	+83%	+$3.28M	1.13%	24
2017 Q2	$4.16M	Buy	+111,500	New	+$4.03M	0.51%	39
2014 Q4	–	Sell	-464,915	Closed	-$13.7M	–	81
2014 Q3	$13.7M	Sell	464,915 -300,000	-39%	-$8.28M	1.44%	21
2014 Q2	$19.2M	Hold	764,915	–	–	1.88%	19
2014 Q1	$19.7M	Sell	764,915 -249,201	-25%	-$6.28M	1.91%	17
2013 Q4	$22.8M	Sell	1,014,116 -1,506,876	-60%	-$29.1M	3.01%	11
2013 Q3	$35.7M	Sell	2,520,992 -70,000	-3%	-$936K	6.35%	3
2013 Q2	$35.4M	Buy	+2,590,992	New	+$35.3M	6.92%	1

Other funds holding NTUS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

CTA

Carillon Tower Advisers St. Petersburg, Florida $16.4B AUM 64.75% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CIM

Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return

Broadfin Capital's NTUS Position: Q2 2018 in Review

Broadfin Capital sold out of Natus Medical Inc (NTUS) in Q2 2018, closing a stake of 113,526 shares — an estimated $3.82M sold.

Broadfin Capital first reported a position in NTUS in Q2 2013 and held it in 10 quarters. The position peaked at $35.7M in Q3 2013. 175 funds tracked by Wall St. Rank hold NTUS as of Q2 2018.

Broadfin Capital reported no remaining Natus Medical Inc position as of Q2 2018 after selling out during the quarter.
Broadfin Capital sold 113,526 Natus Medical Inc shares in Q2 2018, an estimated $3.82M.
Broadfin Capital first reported a position in Natus Medical Inc in Q2 2013 and held it in 10 quarters.
Broadfin Capital's Natus Medical Inc position peaked at $35.7M in Q3 2013.
175 funds tracked by Wall St. Rank held Natus Medical Inc as of Q2 2018.

Based on Broadfin Capital's 13F filing for Q2 2018, filed 14 Aug 2018.